Integrative Cancer Treatments: High Dose Vitamin C IV's
High-dose intravenous vitamin C (IVC) therapy, offered at Extivita, is an innovative approach in cancer treatment, complemented by Hyperbaric Oxygen Therapy (HBOT) and Pulsed Electromagnetic Field (PEMF) therapy. This multifaceted approach aims to enhance overall cancer care.
The Science Behind High-Dose IVC
The scientific basis of high-dose intravenous vitamin C (IVC) therapy in cancer treatment involves several interconnected mechanisms. Vitamin C, known for its antioxidant properties, reaches significantly higher blood levels when administered intravenously. Studies have shown that when administered at supraphysiologic concentrations, ascorbic acid can significantly decrease cell proliferation in a variety of cancer cell lines, including those from prostate, pancreatic, hepatocellular, and colon cancers. This effect is primarily mediated through a chemical reaction that generates hydrogen peroxide, which is cytotoxic to cancer cells. This reaction can lead to the downregulation of specific transcription factors, disruption of iron metabolism, and induction of oxidative DNA damage, leading to cancer cell death
Another important aspect of high-dose IVC therapy is its potential to enhance the effects of certain chemotherapy drugs. Research has indicated that pharmacological doses of ascorbic acid can improve the efficacy of drugs like arsenic trioxide in ovarian cancer cells and gemcitabine in pancreatic cancer cells. Additionally, high-dose ascorbate has been reported to increase radio sensitivity in cells of glioblastoma multiforme, resulting in greater cell death than from radiation treatment alone.
Animal model studies further support these findings. Tumor growth inhibition has been observed in animal models of pancreatic, liver, prostate, mesothelioma, and ovarian cancers following treatment with pharmacological ascorbate. In some models, the combination of ascorbate with standard cancer treatments, such as gemcitabine or radiation therapy, resulted in greater decreases in tumor volume and weight compared to standard treatments alone, suggesting a synergistic effect.
Partnering With Extivita for Cancer Treatment
At Extivita, patient safety and efficacy of treatments are of utmost importance. High-dose intravenous vitamin C (IVC) therapy, known for its general tolerability, is administered with a keen consideration of individual health conditions to ensure safety. Complementing IVC, Extivita offers Hyperbaric Oxygen Therapy (HBOT) and Pulsed Electromagnetic Field (PEMF) therapy. HBOT aids in enhancing the body’s natural healing abilities and potentially amplifies the effectiveness of IVC. Meanwhile, PEMF therapy is aimed at promoting cellular health and recovery. Dedicated to offering advanced and holistic care for cancer patients, Extivita customizes each treatment plan to cater to the unique needs of each patient, ensuring an integrated approach to cancer care. For more information on how these treatments can be part of your cancer care journey, including high-dose IVC, contact us at (919)354-3775 or firstname.lastname@example.org.
Britney Thomas's story is a testament to the power of hope, determination, and advanced medical treatment. After experiencing a life-altering stroke at a young age, Britney's journey with hyperbaric oxygen therapy (HBOT) at UAB Medicine showcases not just her personal...
In the dynamic realm of health care, Hyperbaric Oxygen Therapy (HBOT) emerges as a groundbreaking fusion of physical and mental health treatment. Initially a remedy for deep-sea divers and specialized medical cases, HBOT now marks a significant advancement in modern...